Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P182. Impact of induction dosing on maintenance outcome with adalimumab in Crohn's disease
P182. Prevalence of colonic diverticulosis in patients affected by ulcerative colitis versus adult patients in a single centre
Authors:

E.V. Avallone1, C. Cassieri1, R. Pica1, M. Zippi1, P. Paoluzi1, 1Sapienza University, Internal Medicine and Medical Specialties, “Gastroenterology Unit”, Rome, Italy

P182

New risk score for prediction of relapse in patients with Ulcerative Colitis, Results of a prospective cohort study

Authors:

S.V. Hosseini1, P. Jafari2, S.A. Taghavi3, A. Rezaianzadeh4, M. Moini3, M. Mehrabi3, A.R. Safarpour*3

1Shiraz University of Medical Sciences, Colorectal Research Center, Shiraz, Iran, Islamic Republic of, 2Shiraz University of Medical Sciences, Biostatistics ward, Shiraz, Iran, Islamic Republic of, 3Shiraz University of Medical Sciences, Gastroenterohepatology Research Center, Shiraz, Iran, Islamic Republic of, 4Shiraz University of Medical Sciences, Nutrition and Health School, Shiraz, Iran, Islamic Republic of

P183.

Multidisciplinary approach in IBD patients with arthralgias: usefulness of a combined rheumatologic and gastroenterologic assessment in a prospective study

Authors:

M. Ascolani1, M.S. Chimenti2, S. Onali1, P. Conigliaro2, E. Ballanti2, G. Collalti2, E. Calabrese1, E. Lolli1, C. Petruzziello1, F. Pallone1, R. Perricone2, L. Biancone1, 1Università di Roma Tor Vergata, Medicina dei sistemi, cattedra di Gastroenterologia, Roma, Italy, 2Tor Vergata, Medicina dei Sistemi, Rheumatology, allergology and clinical immunology Unit, Roma, Italy

P183. Once-daily versus twice-daily mesalazine for active ulcerative colitis: Efficacy results from MOTUS, a multicentre, controlled, randomised, investigator-blinded study
P183. Outcomes after ileal pouch anal anastomosis in patients with primary sclerosing cholangitis
Authors:

M. Pavlides1, M. Rahman1, J. Cleland1, R. Gaunt2, S. Travis1, N. Mortensen3, R. Chapman1, 1University of Oxford, Translational Gastroenterology Unit, Oxford, United Kingdom, 2University of Oxford, Statistics, Oxford, United Kingdom, 3University of Oxford, Nuffield Department of Surgery, Oxford, United Kingdom

P183. Thalidomide in immunosuppressors and anti-TNF unresponsive Crohn's disease patients: Efficacy and side effects
P183

Diagnostic value of fecal gelatinase-associated lipocalin as a surrogate marker of inflammation in Inflammatory Bowel Diseases

Authors:

D. Mukhametova1, D. Abdulganieva*1, O. Zinkevich2, N. Saphina2, A. Odintsova3, M. Koporulina2

1Kazan State Medical University, Hospital Therapy with the course of Endocrinology, Kazan, Russian Federation, 2Kazan State Medical Academy, Central Scientific Research Laboratory, Kazan, Russian Federation, 3Republican Clinical Hospital, Gastroenterology, Kazan, Russian Federation

P184.

Mucosal healing does not correspond to histological healing in ulcerative colitis

Authors:

L. Laterza1, I. Scoleri1, S. Bibbò1, E. Gaetani1, G. Bruno1, L. Larosa2, A. Poscia3, A. Amato4, L.M. Minordi2, L. Bonomo2, G. Cammarota1, A. Gasbarrini1, V. Gerardi1, 1Gastroenterology Division, Catholic University of the Sacred Hearth, Rome, Italy, 2Radiology Department, Catholic University of the Sacred Hearth, Rome, Italy, 3Institute of Hygiene, Catholic University of the Sacred Hearth, Rome, Italy, 4Institute of Anestesiology, Catholic University of the Sacred Hearth, Rome, Italy

P184. Effectiveness and tolerability of maintenance methotrexate therapy in Crohn's disease patients; Analysis of a referral hospital-based 10-years intercept cohort
P184. Once-daily versus twice-daily mesalazine for mild to moderately active ulcerative colitis: Mucosal healing and early response data from MOTUS, a multicentre, controlled, randomised, investigator-blinded study
P184. Optimal care in Crohn's disease and ulcerative colitis: how aligned with patients' needs and expectations are health care providers?
Authors:

J.K. Marshall1, P. Lazure2, P. Pare3, U. Chauhan1, J. Bernier4, C. Montgrain4, S. Hayes2, 1McMaster University, Medical Centre, Division of Gastroenterology, Toronto, Canada, 2AXDEV Group, Performance Improvement Research, Brossard, Canada, 3Hôpital du St-Sacrement, CHAUQ, Quebec, Canada, 4Abbvie, an Abbott Corporation, Continuing Health Education, Montreal, Canada

P184

Simplifying the meaning of small bowel thickening

Authors:

S. Campos*, P. Figueiredo, A. Oliveira, C. Sofia

Centro Hospitalar Universitário Coimbra, Gastroenterology, Coimbra, Portugal

P185.

Mucin 16 (MUC16) and mucin 20 (MUC20) over-expression in colonic mucosa is associated with histological remission in patients with ulcerative colitis

Authors:

J. Yamamoto-Furusho1, I. Ascaño-Gutiérrez1, J. Furuzawa-Carballeda2, G. Fonseca-Camarillo1, 1IBD Clinic, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico, 2Instituto Nacional de Ciencias Medicas y Nutricion, Immunology, Mexico, Mexico

P185. Comparison of bowel sonography and entero-MRI for diagnosis of small bowel Crohn's disease
P185. Outcomes of patients with ulcerative colitis: azathioprine tolerant and azathioprine intolerant
Authors:

L.Y. Lee1, T. Shaul1, D. Wilton1, G. Macfaul1, S. Lanzon-Miller1, 1Milton Keynes NHS Foundation Trust, Milton Keynes, United Kingdom

P185. Safety and efficacy of anti-TNFs in a consecutive series of Crohn's disease patients: A single center cohort study
P185

Multidisciplinary approach in IBD patients with arthralgias: Usefulness of a combined reumatologic and gastroenterologic assessment in a prospective study

Authors:

M. Ascolani*1, M.S. Chimenti2, S. Onali1, P. Conigliaro2, E. Ballanti3, G. Collalti2, E. Calabrese1, E. Lolli1, A. Ruffa1, C. Petruzziello1, F. Pallone1, R. Perricone4, L. Biancone1

1Università di Roma Tor Vergata, Medicina dei sistemi, cattedra di Gastroenterologia, Roma, Italy, 2Università degli Studi di Roma "Tor Vergata", Medicina dei Sistemi, Rome, Italy, 3Università degli Studi di Roma "Tor Vergata", Medicina dei Sistemi, Roma, Italy, 4Università degli Studi di Roma "Tor Vergata", Reumatologia, Rome, Italy

P186.

Mitochondrial activity of B-lymphocytes in children with IBD receiving infliximab

Authors:

L. Miroshkina1, S. Petrichuk1, I. Samokhina1, E. Tsimbalova2, A. Potapov2, T. Izmaylova1, M. Venediktova2, G. Semenova1, M. Varichkina2, 1Scientific Centre of Children Health, Cytochemical laboratory, Moscow, Russian Federation, 2Federal State Budgetary Institution “Scientific Centre of Children Health”, Gastroenterology and Hepatology, Moscow, Russian Federation

P186. Granulocyte activation as measured by CD64 expression on PMNs reflects inflammatory load in inflammatory bowel disease